Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Otonomy
6275 Nancy Ridge Drive, Suite 100
San Diego, CA 92121
Phone: 858-242-5200
www.otonomy.com

Otonomy is a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the ear. Otonomy's proprietary technology provides sustained exposure of drugs to the middle and inner ear following a single intratympanic (IT) injection. Otonomy has two product candidates in clinical development. OTO-104 is a steroid that has completed a Phase 1b clinical trial in Meniere's disease patients. OTO-201 is an antibiotic that has recently completed a Phase 1b clinical trial in pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery. Otonomy is advancing both OTO-104 and OTO-201 into late-stage clinical trials. Additional product candidates are expected to target tinnitus and chronic forms of hearing loss.

Key Contact
Name
David A. Weber
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
09/04/13 $45,900,000 Series C Aperture Venture Partners
Avalon Ventures
Domain Associates
Novo Ventures
OrbiMed Advisors
Osage University Partners
RiverVest Venture Partners
TPG Biotech
04/30/14 $49,000,000 Series D Ally Bridge Group
Aperture Venture Partners
Avalon Ventures
Clough Capital Partners
Domain Associates
Federated Kaufmann Funds
Jennison Associates
Novo Ventures
OrbiMed Advisors
Perceptive Advisors
RiverVest Venture Partners
TPG Biotech


Featured Reading